ICMR looks at vaccine launch by Aug. 15
Part of: GS Prelims and Mains III – Science – Health and Medicine
- Covaxin – developed by the Hyderabad-based Bharat Biotech India Ltd (BBIL) got approvals from the Drug Controller General of India for human trials.
- The trials are done on groups of people and are meant to test if the vaccine is safe on humans and produces protective antibodies.
- The potential vaccine in question is a SARS-CoV-2 strain sourced from the ICMR-National Institute of Virology.
- It is envisaged to launch the vaccine latest by 15th August, 2020 after completion of all clinical trials.